Press Releases & Media

Date Title and Summary Additional Formats
Toggle Summary PositiveID’s Chief Science Officer Discusses Company’s Detection of Flu Virus on its FireflyDX Prototype in Interview with CEOLIVE.TV
Dr. Kimothy Smith discusses importance of point of care/point of need detection during flu season DELRAY BEACH, Fla. , Feb. 05, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (the “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, and its ExcitePCR subsidiary
View HTML
Toggle Summary PositiveID’s FireflyDX Prototype Detects Flu Types; Chief Science Officer Explains Why Accurate Flu Detection at Point of Care Enables Smart Treatment Decisions in Interview with SmallCapVoice.com View HTML
Toggle Summary PositiveID Corporation Publishes White Paper and Data on its Successful Detection of Influenza Virus
Disruptive Diagnostic Testing at the Point of Need May Offer Important Defense Against Dangerous Flu Season DELRAY BEACH, Fla. , Jan. 29, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced
View HTML
Toggle Summary PositiveID Corporation Announces Lawrence Livermore National Laboratory Evaluation of PositiveID’s FireflyDX
DELRAY BEACH, Fla. , Jan. 22, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSID), a life sciences company focused on detection and diagnostics, and its ExcitePCR Corporation subsidiary, announced today that Lawrence Livermore National Laboratory has completed an analysis and report of the
View HTML
Toggle Summary PositiveID’s E-N-G Mobile Systems 2017 Bookings Increase 100% Year Over Year
ENG’s mobile labs represent the fastest growing segment of ENG’s specialty vehicle business DELRAY BEACH, Fla. , Jan. 17, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today that 2017
View HTML
Toggle Summary PositiveID Announces 2017 Highlights and Projects Continued 30% Growth
Company expects year-over-year growth of over 30% for the 2017 fourth quarter and 2018 first quarter
View HTML
Toggle Summary PositiveID's ExcitePCR Subsidiary to Present and Exhibit at the Seed Central Tech Showcase on January 11th
Seed Central Showcase facilitates research collaboration between the seed and agbiotech industry and UC Davis to bring science to market faster Kimothy Smith , DVM, EVP and Chief Science Officer of ExcitePCR, will discuss how the company's FireflyDX can be used for agricultural screening DELRAY
View HTML
Toggle Summary PositiveID Corporation Discusses 2017 Accomplishments in New Interview with CEOLIVE.TV
Chairman and CEO William J. Caragol discusses projected consolidated year-over-year revenue growth of more than 30% for the 2017 fourth quarter and 2018 first quarter
View HTML
Toggle Summary PositiveID's ExcitePCR Named Major Player in Molecular Diagnostics Industry Report
ExcitePCR's FireflyDX is designed to bring lab-based testing to the point of need for real-time biological threat detection in less than 30 minutes
View HTML
Toggle Summary PositiveID Commences Production of Next Generation Caregiver Thermometer with Bluetooth Capability
Bluetooth-enabled Caregiver Device Holds Potential to Disrupt the $1 Billion Thermometry Market
View HTML